Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 122 of the 128 references it cites were found in a registry or an index; 66 of the 129 sources its claims cite were checked for support.

Gestational Diabetes Mellitus—Recent Literature Review

Open access

Abstract

GDM is currently the most common medical complication in pregnancy and affects approximately 15% of pregnancies worldwide.

Overview

CoChat Summary

TL;DR

This narrative review summarizes recent literature on gestational diabetes mellitus (GDM), covering epidemiology, pathogenesis, diagnosis, and treatment. It reports that GDM is a common pregnancy complication with rising prevalence and highlights ongoing controversies in diagnostic criteria and treatment, especially regarding metformin and early screening.

Key findings

  • GDM is described as the most common medical complication of pregnancy; the abstract reports it affects approximately 15% of pregnancies worldwide and accounts for approximately 18 million births annually, while the introduction cites IDF estimates of approximately 14.0% (95% CI 13.97–14.04%) of pregnancies worldwide, representing approximately 20 million births annually.
  • Risk factors include age (GDM diagnosed in 6.7% of pregnancies overall but 8.5% in women over 30; highest risk at ages 35–39, OR 10.85 [7.72–15.25] vs. 2.59 [1.84–3.67]), previous GDM (more than sixfold recurrence risk), BMI ≥30 kg/m² (GDM frequency 12.3%), first-line relatives with GDM history (11.6%), combination of these two factors (up to 61%), PCOS (more than twice the percentage of pregnancies with GDM), IVF (50% increase), and summer season.
  • Diagnosis uses IADPSG/WHO criteria (fasting plasma glucose ≥5.1 mmol/L, 1 h ≥10 mmol/L, 2 h ≥8.5 mmol/L during a 75 g OGTT); the HAPO study of 23,316 women showed a linear relationship between elevated glycemia and maternal/neonatal complications, IADPSG criteria produced a threefold increase in GDM diagnoses, and in a trial of 23,792 pregnant women one-step screening doubled GDM diagnosis without affecting LGA, adverse perinatal outcomes, primary Caesarean section, gestational hypertension, or pre-eclampsia.
  • Treatment is primarily diet and increased exercise, with insulin, glibenclamide, and metformin used to intensify treatment; the MiG trial of 751 women found metformin alone or with supplemental insulin was not associated with increased perinatal complications, exercise reduced GDM risk by 38% (RR 0.62, 95% CI 0.41–0.94), 24%, and 42% (RR 0.58, 95% CI 0.37–0.90, p = 0.01) in different analyses, and ADA/ACOG still recommend insulin as primary medical treatment when lifestyle goals are not achieved.

Methods

  • Narrative literature review analyzing currently available literature on the epidemiology, pathogenesis, diagnosis, and treatment of GDM, based on reviews, original articles, and meta-analyses published in English in the last 10 years.
  • Literature search conducted from 1 January 2021 to 31 March 2022 using Web of Science, PubMed, EMBASE, Cochrane, Open Grey, and Grey Literature Report, with MeSH terms including “gestational diabetes”, “pregnancy induced diabetes”, “hyperglycemia”, “glucose intolerance”, “insulin resistance”, “prevalence”, “incidence”, “GDM treatment”, and “behavioral treatment”, used alone or in combination.
  • Analysis was a narrative synthesis; no formal systematic review protocol, meta-analysis, or quality appraisal is described.

Limitations

  • The paper states that due to the lack of randomized clinical trials, it is extremely difficult to propose an unambiguous and uniform management model; treatment is based on consensus and expert opinion; Cochrane analyses show a lack of unambiguous data on the correlation between intensity of glycemic control and obstetric outcomes; many doubts regarding diagnostic criteria and treatment remain; and screening/treatment for GDM early in pregnancy are very controversial due to lack of data from large randomized controlled trials.
  • Evident from the text: this is a narrative review without described systematic quality assessment or PRISMA-style reporting, the search was restricted to English-language publications from the last 10 years, and prevalence figures differ between the abstract (approximately 15%, 18 million births annually) and the introduction (approximately 14.0%, 20 million births annually).
  • Evident from the provided text: several subsection headings appear without accompanying content (e.g., 4.4.1 Insulin Resistance and 4.6.1–4.6.3 headings), limiting assessment of those specific details.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/jcm11195736

Cites

122 of 122 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

51 Valid · 2 Not valid · 35 Not checked · 8 Own results and interpretations

45 more claims · 22 with their cited sources checked

Create a free account to see all 96 claims and to verify the 13 references still open.

See all claims — free account
  • It may state two separate claims as one. 41
  • Probably not a substantial claim. 11
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 128 references

Research works printed but not linked: 3

  1. Kumar, 2020, Autoimmunity in Gestational Diabetes A Decade after the HAPO Study, Front. Diabetes, 28, 234
  2. Chao, 2019, Dietary control plus nutrition guidance for blood glucose and pregnancy outcomes in women with gestational diabetes, Int. J. Clin. Exp. Med., 12, 2773
  3. Rasmussen, K.M., and Yaktine, A.L. (2009). Weight Gain During Pregnancy: Reexamining the Guidelines (2009), The National Academies Press.

Cited by

See all 223

Metadata

Authors
Modzelewski, R., Stefanowicz-Rutkowska, M. M., Matuszewski, W., & Bandurska-Stankiewicz, E. M.
Affiliations
  • University of Warmia and Mazury in Olsztyn (PL)
  • Wroclaw Medical University (PL)
Corresponding author
Stefanowicz-Rutkowska, Magdalena Maria
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2022-09-28
Volume
11
Issue
19
Pages
5736
ISSN
2077-0383 (ISSN-L)
OpenAlex
W4297478345
Cited by
223
References
128
Citations by year
2026: 65 · 2025: 74 · 2024: 62 · 2023: 22
FWCI
7.94
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
gestational diabetes mellitus, hyperglycemia in pregnancy, risk factors, pathogenesis, SARS-CoV-2, diagnosis, treatment, insulin, metformin, glibenclamide, diet and exercise, type 2 diabetes risk, perinatal complications, economic burden

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gestational Diabetes Mellitus—Recent Literature Review. https://app.cochat.ai/papers/10.3390/jcm11195736
The paper
Modzelewski, R., Stefanowicz-Rutkowska, M. M., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2022). Gestational Diabetes Mellitus—Recent Literature Review. Journal of Clinical Medicine. https://doi.org/10.3390/jcm11195736

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.